Swedish Child Diabetes Foundation Report issue

Foundation Phase 2
Founded: Sweden

Organization Overview

First Clinical Trial
2013
NCT01785108
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Swedish Child Diabetes Foundation

Active Ingredients

Drugs in Phase 2 Trials (4)

diamyd (3 trials)

etanercept (enbrel) (1 trial)

ibuprofen (motrin) (1 trial)

vitamin d3 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4